Skip to main content
. Author manuscript; available in PMC: 2010 Apr 28.
Published in final edited form as: J Neurointerv Surg. 2010 Mar;2(1):67–70. doi: 10.1136/jnis.2009.001768

Table 1.

Characteristics of patients in each sedation category*

No Sedation (n=40) Mild Sedation (n=9) Heavy Sedation (n=9) Pharmacological Paralysis (n=17) All Groups (n=75) p-value**
Age 64.6 ± 11.4 63.6 ± 10.3 64.0 ± 12.2 62.8 ± 12.6 64.0 ± 11.5 0.98
Baseline NIHSS 17.3 ± 4.5 19.4 ± 8.3 21.0 ± 5.5 21.2 ± 4.0 18.9 ± 5.3 0.03
Male Gender 26 (65.0%) 4 (44.4%) 3 (33.3%) 11 (64.7%) 44 (58.7%) 0.26
Non-White 7 (17.5%) 2 (22.2%) 1 (11.1%) 5 (29.4%) 15 (20.0%) 0.68
Atrial Fibrillation 11 (27.5%) 2 (22.2%) 2 (22.2%) 3 (17.7%) 18 (24.3%) 0.95
Baseline Glucose 120.1 ± 42.6 116.1 ± 19.4 169.0 ± 104.2 125.2 ± 38.8 126.6 ± 52.5 0.68
Baseline SBP 143.8 ± 22.6 150.1 ± 10.4 143.7 ± 20.9 147.4 ± 21.0 145.4 ± 20.7 0.83
Left Hemisphere Involved 20 (50.0%) 6 (66.7%) 8 (88.9%) 11 (64.7%) 45 (60.0%) 0.17
Aphasia Present 19 (47.5%) 6 (66.7%) 8 (88.9%) 11(64.7%) 44 (58.7%) 0.11
ICAT occlusion 7 (18.4) 1 (11.1) 2 (22.2) 8 (47.1) 18 (24.7) 0.12
Onset to IV treatment (min) 141.6 ± 33.5 127.7 ± 38.3 139.1 ± 28.4 139.0 ± 25.5 139.1 ± 31.6 0.75
Received IA treatment 25 (62.5%) 8 (88.9%) 8 (88.9%) 12 (70.6%) 53 (70.7%) 0.31
Onset to IA treatment (min) 231.6 ± 55.3 234.6 ± 55.0 238.5 ± 35.4 236.8 ± 57.7 234.3 ± 51.9 0.99
Duration of procedure (min) 111.2 ± 59.3 119.9 ± 65.9 150.9 ± 44.4 136.8 ± 65.7 123.1 ± 60.5 0.26
*

Categorical variables are described using n (%), and continuous variables are presented as mean ± standard deviation

**

P-values represent variation across all 4 sedation categories.